Pharmacologic management of psychiatric illness during pregnancy: Dilemmas and guidelines

American Journal of Psychiatry

Volumn 153, Issue 5, 1996, Pages 592-606

  Altshuler, Lori L ^a   Cohen, Lee ^b   Szuba, Martin P ^b   Burt, Vivien K ^b   Gitlin, Michael ^b   Mintz, Jim ^b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; DIAZEPAM; LITHIUM; NEUROLEPTIC AGENT; PHENOTHIAZINE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; BEHAVIOR DISORDER; CONGENITAL MALFORMATION; HUMAN; MENTAL DISEASE; PERINATAL DRUG EXPOSURE; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; TERATOGENICITY; TREATMENT PLANNING;

EID: 0029881029     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.153.5.592     Document Type: Article

References (217)

1. Kupfer DJ, Frank E, Perel JM, Cornes C, Mallinger AG, Thase ME, McEachran AB, Grochocinski VJ: Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1992; 49:769-773
2. Suppes T, Baldessarini RJ, Faedda GL, Tohen M: Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 1991; 48:1082-1088
3. Pollack MH, Smoller JW: The longitudinal course and outcome of panic disorder. Psychiatr Clin North Am 1995; 18:785-801
4. Dencker SJ, Malm U, Lepp M: Schizophrenic relapse after drug withdrawal is predictable. Acta Psychiatr Scand 1986; 73:181-185
5. Carpenter WT Jr, Hanlon TE, Heinrichs DW, Summerfelt AT, Kirkpatrick B, Levine J, Buchanan RW: Continuous versus targeted medication in schizophrenic outpatients: outcome results. Am J Psychiatry 1990; 147:138-1148
6. Mortola JF: The use of psychotropic agents in pregnancy and lactation. Psychiatr Clin North Am 1989; 12:69-87
7. Miller LJ: Clinical strategies for the use of psychotropic drugs during pregnancy. Psychiatry Med 1991; 9:275-298
8. Cohen LS: Psychotropic drug use in pregnancy. Hosp Community Psychiatry 1989; 40:566-567
9. Dicke JM: Teratology: principles and practice. Med Clin North Am 1989; 73:567-581
10. Nelson K, Holmes LB: Malformations due to presumed spontaneous mutations in newborn infants. N Engl J Med 1989; 320: 19-23
11. American Medical Association: Drug interactions and adverse drug reactions, in AMA Drug Evaluations. Chicago, AMA, 1983, pp 31-44
12. Auerbach JG, Hans SL, Marcus J, Maeir S: Maternal psychotropic medication and neonatal behavior. Neurotoxicol Teratol 1992; 14:399-406
13. Vernadakis A, Parker KK: Drugs and the developing central nervous system. Pharmacol Ther 1980; 11:593-647
14. Vorhees CV, Brunner RL, Butcher RE: Psychotropic drugs as behavioral teratogens. Science 1979; 205:1220-1225
15. Rieder RO, Rosenthal D, Wender P, Blumenthal H: The offspring of schizophrenics: fetal and neonatal deaths. Arch Gen Psychiatry 1975; 32:200-211
16. Sobel DE: Fetal damage due to ECT, insulin coma, chlorpromazine or reserpine. Arch Gen Psychiatry 1960; 2:606-611
17. Moriarty AJ, Nance NR: Trifluoperazine and pregnancy. Can Med Assoc J 1963; 88:375-376
18. Milkovich L, van den Berg BJ: An evaluation of the teratogenicity of certain antinauseant drugs. Am J Obstet Gynecol 1976; 125: 244-248
19. Rumeau-Rouquette C, Goujard J, Huel G: Possible teratogenic effects of phenothiazines in human beings. Teratology 1977; 15: 57-64
20. Slone D, Siskind V, Heinonen OP, Monson RR, Kaufman DW, Shapiro S: Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol 1977; 128:486-488
21. Edlund MJ, Craig TJ: Antipsychotic drug use and birth defects: an epidemiologic reassessment. Compr Psychiatry 1984; 25: 32-38
22. Fleiss JL: Statistical Methods for Rates and Proportions, 2nd ed. New York, John Wiley & Sons, 1981
23. Ayd FJ: Haloperidol: 15 years of clinical experience. Dis Nerv Syst 1972; 33:459-469
24. Kopelman AE, McCullar FW, Heggeness L: Limb malformations following maternal use of haloperidol. JAMA 1975; 231: 62-64
25. Hanson JW, Oakley GP Jr: Haloperidol and limb deformity (letter). JAMA 1975; 231:26
26. Van Waes A, Van de Velde E: Safety evaluation of haloperidol in the treatment of hyperemesis gravidum. J Clin Pharmacol 1969; 9:224-237
27. Waldman MD, Safferman AZ: Pregnancy and clozapine (letter). Am J Psychiatry 1993; 150:168-169
28. Hill RM, Desmond MM, Kay JK: Extrapyramidal dysfunction in an infant of a schizophrenic mother. J Pediatr 1966; 69:589-595
29. Tamer A, McKey R, Arias D, Worley L, Fogel BJ: Phenothiazine-induced extrapyramidal dysfunction in the neonate. J Pediatr 1969; 75:479-480
30. Desmond MM, Rudolph AJ, Hill RM, Claghorn JL, Dreesen PR, Burgdorff I: Behavior alterations in infants born to mothers on psychoactive medication during pregnancy, in Congenital Mental Retardation. Edited by Farrel G. Austin, University of Texas Press, 1967, pp 235-244
31. Scokel PW, Jones WD: Infant jaundice after phenothiazine drugs for labour: an enigma. Obstet Gynecol 1962; 20:124-127
32. Falterman LG, Richardson DJ: Small left colon syndrome associated with maternal ingestion of psychotropic drugs. J Pediatr 1980; 97:300-310
33. Kris EB: Children of mothers maintained on pharmacotherapy during pregnancy and postpartum. Curr Ther Res 1965; 7:785-789
34. Clark CVH, Gorman D, Vernadakis A: Effects of prenatal administration of psychotropic drugs on behavior of developing rats. Dev Psychobiol 1970; 3:225-235
35. Golub M, Kornetsky C: Seizure susceptibility and avoidance conditioning in adult rats treated prenatally with chlorpromazine. Dev Psychobiol 1974; 7:79-88
36. Spear LP, Shalaby IA, Brick J: Chronic administration of halopendol during development: behavioral and psychopharmacological effects. Psychopharmacology (Berl) 1980; 70:47-58
37. Cagiano R, Barfield RJ, White NR, Pleim ET, Weinstein M, Cuomo V: Subtle behavioral changes produced in rat pups exposed in utero to haloperidol. Eur J Pharmacol 1988; 157:45-50
38. Hemonen OP, Slone D, Shapiro S: Birth Defects and Drugs in Pregnancy. Littleton, Mass, Publishing Services Group, 1977
39. Saxen I: Cleft palate and maternal diphenhydramine intake (letter). Lancet 1974; 1:407-408
40. Nelson MM, Forfar JO: Associations between drugs administered during pregnancy and congenital anomalies in the fetus. Br Med J 1971; 1:523-527
41. Aselton P, Jick H, Milunsky A, Hunter JR, Stergachis A: First-trimester drug use and congenital disorders. Obstet Gynecol 1985; 65:451-455
42. Parkin DE: Probable Benadryl withdrawal manifestations in a newborn infant. J Pediatr 1974; 85:580
43. Hirsch MS, Swartz MN: Antiviral agents. N Engl J Med 1980; 302:903-907
44. Nora JJ, Nora AH, Way GL: Cardiovascular maldevelopment associated with maternal exposure to amantadine (letter). Lancet 1975; 2:607
45. Morrow AW: Imipramine and congenital abnormalities (letter). NZ Med J 1972; 75:228-229
46. Misri S, Sivertz K: Tricyclic drugs in pregnancy and lactation: a preliminary report. Int J Psychiatry Med 1991; 21:157-171
47. Pastuszak A, Schick-Boschetto B, Zuber C, Feldkamp M, Pinelli M, Sihn S, Donnenfeld A, McCormack M, Leen-Mitchell M, Woodland C, Gardner A, Hom M, Koren G: Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 1993; 269:2246-2248
48. Scanlon FJ: Use of antidepressant drugs during the first trimester (letter). Med J Aust 1969; 2:1077
49. Crombie DI, Pinsent RJ, Fleming D: Imipramine in pregnancy. Br Med J 1972; 1:745
50. Sim M: Imipramine and pregnancy. Br Med J 1972; 2:45
51. Kuenssberg EV, Knox JD: Imipramine in pregnancy. Br Med J 1972; 2:292
52. Rachelefsky GS, Flynt JW, Ebbin AJ, Wilson MG: Possible teratogenicity of tricyclic antidepressants (letter). Lancet 1972; 1: 838
53. Jacobs D: Imipramine (Tofranil) (letter). S Afr Med J 1972; 46: 1023
54. Banister P, Dafoe C, Smith ESO, Miller J: Possible teratogenicity of tricyclic antidepressants (letter). Lancet 1972; 1:838-839
55. Idanpaan-Heikkila J, Saxen L: Possible teratogenicity of imipramine-chloropyramine. Lancet 1973; 2:282-284
56. Briggs G, Freeman R, Yaffe S: Drugs in Pregnancy and Lactation. Baltimore, Williams & Wilkins, 1994
57. Ware MR, DeVane CL: Imipramine treatment of panic disorder during pregnancy. J Clin Psychiatry 1990; 51:482-484
58. Eggermont E: Withdrawal symptoms in neonates associated with maternal imipramine therapy. Lancet 1973; 2:680
59. Schimmell MS, Katz EZ, Shaag Y, Pastuszak A, Koren G: Toxic neonatal effects following maternal clomipramine therapy. Clin Toxicology 1991; 29:479-484
60. Cowe L, Lloyd DJ, Dawling S: Neonatal convulsions caused by withdrawal from maternal clomipramine. Br Med J 1982; 284: 1837-1838
61. Webster PAC: Withdrawal symptoms in neonates associated with maternal antidepressant therapy. Lancet 1973; 2:318-319
62. Shearer WT, Schreiner RL, Marshall RE: Urinary retention in a neonate secondary to maternal ingestion of nortriptyline. J Pediatr 1972; 81:570-572
63. Ali SF, Buelkesam J, Newport L: Early neurobehavioral and neurochemical alterations in rats prenatally exposed to imipramine. Neurotoxicology 1986; 7:365-380
64. Del Rio J, Montero D, De Ceballos M: Long lasting changes after perinatal exposure to antidepressants. Prog Brain Res 1988; 73:173-187
65. Coyle IR: Changes in developing behavior following prenatal administration of imipramine Pharmacol Biochem Behav 1975; 3:799-807
66. File SE, Tucker JC: Prenatal treatment with clomipramine: effects of the behaviour of male and female adolescent rats. Psychopharmacology (Berl) 1984; 82:221-224
67. Jason KM, Cooper TB, Friedman E: Prenatal exposure to imipramine alters early behavioral development and beta adrenergic receptors in rats. J Pharmacol Exp Ther 1981; 217:461-466
68. De Ceballos ML, Benedi A, De Felipe C, Del Rio J: Prenatal exposure of rats to antidepressants enhances agonist affinity of brain dopamine receptors and dopamine-mediated behaviour. Eur J Pharmacol 1985; 116:257-262
69. 2 receptors and serotonin-mediated behaviour. Neuropharmacology 1985; 24:947-952
70. 3H-imipramine binding sites in rat cerebral cortex after prenatal exposure to antidepressants. Life Sci 1990; 46:1619-1626
71. Cooper GL: The safety of fluoxetine: an update. Br J Psychiatry 1988; 153(suppl 3):77-86
72. Goldstein DJ, Marvel DC: Psychotropic drug use during pregnancy (letter). JAMA 1993; 270:2177
73. Inman W, Kubotu K, Pearce G: Prescription event monitoring of paroxetine. Prescription Event Monitoring Reports 1993; 1-44
74. Spencer MJ: Fluoxetine hydrochloride (Prozac) toxicity in the neonate. Pediatrics 1993; 92:721-722
75. Cabrera FM, Battaglia G: Delayed decreases in brain 5-HT 2a and 2c receptor density and function in male rat progeny following prenatal fluoxetine. J Pharmacol Exp Ther 1994; 269: 637-645
76. Compendium of Drug Therapy (The Obstetrician and Gynecologist's). New York, Biomedical Information Corp, 1984
77. Poulson E, Robson JM: Effect of phenelzine and some related compounds on pregnancy. J Endocrinol 1964; 30:205-215
78. Chiarello RJ, Cole JO: The use of psychostimulants in general psychiatry: a reconsideration. Arch Gen Psychiatry 1987; 44: 286-295
79. Levin JN: Amphetamine ingestion with biliary atresia. J Pediatr 1971; 79:130-131
80. Nora JJ, Trasler DG, Fraser FC: Malformation in mice induced by dextroamphetamine sulfate. Lancet 1965; 2:1021-1022
81. Nora JJ, McNamara DG, Fraser FC: Dextroamphetamine sulphate and human malformations. Lancet 1967; 1:570-571
82. Kalter H, Warkany J: Congenital malformations. N Engl J Med 1983; 308:491-497
83. Zierler S: Maternal drugs and congenital heart disease. Obstet Gynecol 1985; 65:155-165
84. Milkovich L, van den Berg BJ: Effects of antenatal exposure to anorectic drugs. Am J Obstet Gynecol 1977; 129:637-642
85. Nora JJ, Vargo TA, Nora AH, Love KE, McNamara DG: Dexamphetamine: a possible environmental trigger in cardiovascular malformations. Lancet 1970; 1:1290-1291
86. Ramer CM: The case history of an infant born to an amphetamine addicted mother. Clin Pediatr 1974; 13:596-597
87. Oro AS, Dixon SD: Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr 1987; 111: 571-578
88. Eriksson M, Billing L, Steneroth G, Zetterstrom R: Health and development of 8-year old children whose mothers abuse amphetamine during pregnancy. Acta Paediatr Scand 1989; 78: 944-949
89. Goldstein HH, Weinberg J, Sankstone MI: Shock therapy in psychosis complicating pregnancy, a case report. Am J Psychiatry 1941; 98:201-202
90. Impastato DJ, Gabriel AR, Lardara HH: Electric and insulin shock therapy during pregnancy. Dis Nerv Syst 1964; 25:542-546
91. Remick RA, Maurice WL: ECT in pregnancy (letter). Am J Psychiatry 1978; 135:761-762
92. Forssman H: Follow-up study of sixteen children whose mothers were given electric convulsive therapy during gestation. Acta Psychiatr Neurol Scand 1955; 30:437-441
93. Miller LJ: Use of electroconvulsive therapy during pregnancy. Hosp Community Psychiatry 1994; 45:444-450
94. Ferrill MJ, Kehoe WA, Jacisin JJ: ECT during pregnancy: physiologic and pharmacologic considerations. Convulsive Therapy 1992; 8:186-200
95. Weinstein MR: The international register of lithium babies. Drug Information J 1976; 10:94-101
96. Schou M, Goldfield MD, Weinstein MR, Villeneuve A: Lithium and pregnancy, 1: report from the Register of Lithium Babies. Br Med J 1973; 2:135-136
97. Jacobson SJ, Jones K, Johnson K, Ceolin L, Kaur P, Sahn D, Donnenfeld AE, Rieder M, Santelli R, Smythe J, Pastuszak A, Einarson T, Koren G: Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester. Lancet 1992; 339:530-533
98. Kallen B, Tandberg A: Lithium and pregnancy: a cohort study on manic-depressive women. Acta Psychiatr Scand 1983; 68: 134-139
99. Zalzstein E, Koren G, Einarson T, Freedom RM: A case-control study on the association between first trimester exposure to lithium and Ebstein's anomaly. Am J Cardiol 1990; 65:817-818
100. Kallen B: Comments on teratogen update: lithium (letter). Teratology 1958; 38:597
101. Edmonds LD, Oakley GP: Ebstein's anomaly and maternal lithium exposure during pregnancy. Teratology 1990; 41:551-552
102. Sipek A: Lithium and Ebstein's anomaly. Cor et Vasa 1989; 31:149-156
103. Cohen LS, Friedman JM, Jefferson JW, Johnson EM, Weiner ML: A reevaluation of risk of in utero exposure to lithium. JAMA 1994; 271:146-150; correction, 271:1485
104. Schou M, Amdisen A: Lithium and the placenta (letter). Am J Obstet Gynecol 1975; 122:541
105. Woody JN, London WL, Wilbanks GD: Lithium toxicity in a newborn. Pediatrics 1971; 47:94-96
106. Schou M: Whac happened to the lithium babies? a follow-up study of children born without malformations. Acta Psychiatr Scand 1976; 54:193-197
107. Paskind HA, Brown M: Constitutional differences between deteriorated and nondeteriorated patients with epilepsy. Arch Neurol Psychiatry 1936; 36:1037-1044
108. Koch S, Hortman A, Jager-Roman E, Rating D, Helge H: Major malformations in children of epileptic parents - due to epilepsy or therapy? in Epilepsy, Pregnancy, and the Child. Edited by Janz D, Richens A, Bossi L, Helge H, Schmidt D. New York, Raven Press, 1982, pp 313-316
109. Delgado-Escueta AV, Janz D: Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy. Neurology 1992; 42(suppl 5):149-160
110. Fisher JE, Vorhees CV: Developmental toxicity of antiepileptic drugs: relationship to postnatal dysfunction. Pharmacol Res 1992; 26:207-221
111. So EL: Update on epilepsy. Med Clin N Am 1993; 77:203-214
112. Rosa F: Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 1991; 324:674-677
113. Lindhout D, Meinardi H, Meijer JW, Nau H: Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations. Neurology 1992; 42(suppl 5):94-110
114. Lammer EJ, Sever LE, Oakley GP: Teratogen update: valproic acid. Teratology 1987; 35:465-473
115. Omtzigt JGC, Los FJ, Grobbee DE, Pijpers L, Jahoda MG, Brandenburg H, Stewart PA, Gaillard HL, Sachs ES, Wladimiroff JW, Lindhout D: The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. Neurology 1992; 42(suppl 5):119-125
116. Battino D, Binelli S, Caccamo ML, Canevini MP, Canger R, Como ML, Croci D, De Giambattista M, Granata T, Pardi G, Avanzini G: Malformation in offspring of 305 epileptic women: a prospective study. Acta Neurol Scand 1992; 85:204-207
117. Koch S, Losche G, Jager-Roman EJ, Jacob S, Rating D, Deichl A, Helge H: Major and minor birth malformations and antiepileptic drugs. Neurology 1992; 42(suppl 5):83-88
118. Nakane Y, Okuma T, Takahashi R, Sato Y, Wada T, Sato T, Fukushima Y, Kumashiro H, Ono T, Takahashi T, Aoki Y, Kazamatsuri H, Inami M, Komai S, Seino M, Miyakoshi M, Tanimura T, Hazama H, Kawahara R, Otsuki S, Hosokawa K, Inanaga K, Nakazawa Y, Yamamoto K: Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan. Epilepsia 1980; 21:663-680
119. Shaw GM, Wasserman CR, O'Malley CD, Lammer EJ, Finnell RH: Orofacial clefts and maternal anticonvulsant use. Reprod Toxicol 1995; 1:97-98
120. Jager-Roman E, Deichl A, Jakob S, Hartmann AM, Koch S, Rating D, Steldinger R, Nau H, Helge H: Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acid. J Pediatr 1986; 108:997-1004
121. Jones KL, Lacro RV, Johnson KA, Adams J: Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 1989; 320:1661-1666
122. Gaily E, Granstrom ML: Minor anomalies in children of mother with epilepsy. Neurology 1992; 42(suppl 5):128-131
123. Granstrom ML, Gaily E: Psychomotor development in children of mothers with epilepsy. Neurology 1992; 42(suppl 5):144-148
124. Scolnik D, Nulman I, Rovet J, Gladstone D, Czuchta D, Gardner HA, Gladstone R, Ashby P, Weksberg R, Einarson T, Koren G: Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA 1994; 271:767-770
125. Langman J: Medical Embryology: Human Development - Normal and Abnormal, 3rd ed. Baltimore, Williams & Wilkins, 1975
126. Milkovich L, van den Berg BJ: Effects of prenatal meprobamate and chlordiazepoxide hydrochloride on human embryonic and fetal development. N Engl J Med 1974; 291:1268-1271
127. Aarskog D: Association between maternal intake of diazepam and oral clefts (letter). Lancet 1975; 2:921
128. Crombie DL, Pinsent RJ, Fleming DM, Rumeau-Rouquette C, Goujard J, Huel G: Fetal effects of tranquilizers in pregnancy (letter). N Engl J Med 1975; 293:198-199
129. Hartz SC, Heinonen OP, Shapiro S, Siskind V, Slone D: Antenatal exposure to meprobamate and chlordiazepoxide in relation to malformations, mental development, and childhood mortality. N Engl J Med 1975; 292:726-728
130. Safra MJ, Oakley GP Jr: Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet 1975; 2:478-480
131. Saxén I, Saxén L: Association between maternal intake of diazepam and oral clefts (letter). Lancet 1975; 2:498
132. Czeizel A: Diazepam, phenytoin, and aetiology of cleft lip and/ or cleft palate (letter). Lancet 1976; 1:810
133. Rosenberg L, Mitchell AA, Parsells JL, Pshayan H, Louik C, Shapiro S: Lack of relation of oral clefts to diazepam use during pregnancy. N Engl J Med 1983; 309:1282-1285
134. Shiono PH, Mills JL: Oral clefts and diazepam use during pregnancy. N Engl J Med 1984; 311:919-920
135. Czeizel A, Rácz J: Evaluation of drug intake during pregnancy in the Hungarian case-control surveillance of congenital anomalies. Teratology 1990; 42:505-512
136. Laegreid L, Olegärd R, Conradi N, Hagberg G, Wahlström J, Abrahamsson L: Congenital malformations and maternal consumption of benzodiazepines: a case-control study. Dev Med Child Neurol 1990; 32:432-441
137. Bergman U, Rosa FW, Baum C, Wiholm BE, Faich GA: Effects of exposure to benzodiazepine during fetal life. Lancet 1992; 340:694-696
138. St Clair SM, Schirmer RG: First-trimester exposure to alprazolam. Obstet Gynecol 1992; 80:843-846
139. Czeizel A, Lendvay A: In-utero exposure to benzodiazepines (letter). Lancet 1987; 1:628
140. Sullivan FM, McElhatton PR: A comparison of the teratogenic activity of the antiepileptic drugs carbamazepme, clonazepam, ethosuximide, phenobarbital, phenytom, and pyrimidone in mice. Toxicol Appl Pharmacol 1977; 40:365-378
141. Fisher JB, Edgren BE, Mammel MC, Coleman JM: Neonatal apnea associated with maternal clonazepam therapy: a case report. Obstet Gynecol 1985; 66(Sept suppl):34S-35S
142. Gillberg C: "Floppy infant syndrome" and maternal diazepam (letter). Lancet 1977; 2:244
143. Mazzi E: Possible neonatal diazepam withdrawal: a case report. Am J Obstet Gynecol 1977; 129:586-587
144. Rementeria JL, Bhatt K: Withdrawal symptoms in neonates from intrauterine exposure to diazepam. J Pediatr 1977; 90: 123-126
145. Rowlatt RJ: Effect of maternal diazepam on the newborn (letter). Br Med J 1978; 1:985
146. Speight AN: Floppy-infant syndrome and maternal diazepam and/or nitrazepam (letter). Lancet 1977; 2:878
147. Whitelaw AGL, Cummings AJ, McFadyen IR: Effect of maternal lorazepam on the neonate. Br Med J 1981; 282:1106-1108
148. Gai N, Grimm VE: The effect of prenatal exposure to diazepam on aspects of postnatal development and behavior in rats. Psychopharmacology (Berl) 1982; 78:225-229
149. Kellogg CK, Chisholm J, Simmons RD, Ison JR, Miller RK: Neural and behavioral consequences of prenatal exposure to diazepam. Monographs in Neural Sciences 1983; 9:119-129
150. Kellogg CK, Tervo D, Ison J, Parisi T: Prenatal exposure to diazepam alters behavioral development in rats. Science 1989; 207:205-207
151. Kellogg CK: Benzodiazepines: influence on the developing brain. Prog Brain Res 1988; 73:207-228
152. De Salvia MA, Cagiano R, Lacomba C, Cuomo V: Neurobehavioral changes produced by developmental exposure to benzodiazepines. Dev Pharmacol Ther 1990; 15:173-177
153. Kellogg CK, Primus RJ, Bitran D: Sexually dimorphic influence of prenatal exposure to diazepam on behavioral responses to environmental challenge and on gamma-aminobutyric acid (GABA)-stimulated chloride uptake in the brain. J Pharmacol Exp Ther 1991; 256:259-265
154. Lauer JA, Adams PM, Johnson KM: Perinatal diazepam exposure: behavioral and neurochemical consequences. Neurotoxicol Teratol 1987; 9:213-219
155. Pankaj V, Brain PF: Effects of prenatal exposure to benzodiazepine-related drugs on early development and adult social behaviour in Swiss mice, I: agonists. Gen Pharmacol 1991; 22:33-41
156. Viggedal G, Hagberg BS, Laegreid L, Aronsson M: Mental development in late infancy after prenatal exposure ro benzodiazepines - a prospective study. J Child Psychol Psychiatry 1993; 34:295-305
157. Jeffries WS, Bochner F: The effect of pregnancy on drug pharmacokinetics. Med J Aust 1988; 149:675-677
158. Rayburn WF, Andresen BD: Principles of perinatal pharmacology, in Drug Therapy in Obstetrics and Gynecology. Edited by Rayburn WF, Zuspan F. Norwalk, Conn, Appleton-Century-Crofts, 1982, pp 1-8
159. Wood SM, Hytten FE: The fate of drugs in pregnancy. Clin Obstet Gynaecol 1981; 8:255-259
160. Wisner KL, Perel JM, Wheeler SB: Tricyclic dose requirements across pregnancy. Am J Psychiatry 1993; 150:1541-1542
161. Schou M, Amdisen A, Steenstrup OR: Lithium and pregnancy, II: hazards to women given lithium during pregnancy and delivery. Br Med J 1973; 2:137-138
162. Altshuler LL, Hendrick VC: Pregnancy and psychotropic medication: changes in blood levels. J Clin Psychopharmacol 1996; 16:78-80
163. McNeil T, Kaij L, Malmquist-Larsson A: Women with nonorganic psychosis: factors associated with pregnancy's effect on mental health. Acta Psychiatr Scand 1984; 70:209-219
164. Krener P, Simmons MK, Hansen RL, Treat JN: Effect of pregnancy on psychosis: life circumstances and psychiatric symptoms. Int J Psychiatry Med 1989; 19:65-84
165. Spielvogel A, Wile J: Treatment and outcomes of psychotic patients during pregnancy and childbirth. Birth 1992; 19:131-137
166. Wrede G, Mednick SA, Huttunen MO, Nilsson CG: Pregnancy and delivery complications in the births of an unselected series of Finnish children with schizophrenic mothers. Acta Psychiatr Scand 1980; 62:369-381
167. Miller LJ: Psychotic denial of pregnancy: phenomenology and clinical management. Hosp Community Psychiatry 1990; 41: 1233-1237
168. Davidson J, Robertson E: A followup study of postpartum illness 1946-1978. Acta Psychiatr Scand 1985; 71:451-457
169. McNeil JF: A prospective study of postpartum psychosis in a high risk group: relationship to demographic and psychiatric history characteristics. Acta Psychiatr Scand 1987; 73:35-43
170. Gotlib IH, Whiffen VE, Mount JH, Milne K, Cordy NI: Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum. J Consult Clin Psychol 1989; 57:269-274
171. O'Hara MW: Social support, life events, and depression during pregnancy and the puerperium. Arch Gen Psychiatry 1986; 43: 569-573
172. Zajicek E: Psychiatric problems during pregnancy, in Pregnancy: A Psychological and Social Study. Edited by Wolkind S, Zajicek E. London, Academic Press, 1990, pp 57-73
173. Kendell RE, Wainwright S, Hailey A, Shannon B: The influence of childbirth on psychiatric morbidity. Psychol Med 1976; 6: 297-302
174. Zuckerman B, Bauchner H, Parker S, Cabral H: Maternal depressive symptoms during pregnancy, and newborn irritability. J Dev Behav Pediatr 1990; 11:190-194
175. Cutrona CE: Causal attributions and perinatal depression. J Abnorm Psychol 1983; 92:161-172
176. Beck AT, Rush AJ, Shaw BF, Emery G: Cognitive Therapy of Depression. New York, Guilford Press, 1979
177. Klerman GL, Weissman MM, Rounsaville BJ, Chevron ES: Interpersonal Psychotherapy of Depression. New York, Basic Books, 1984
178. Lam RW, Kripke DF, Gillin JC: Phototherapy for depressive disorders: a review. Can J Psychiatry 1989; 34:140-147
179. Wu JC, Bunney WE: The biological basis of antidepressant response to sleep deprivation and relapse: review and hypothesis. Am J Psychiatry 1990; 147:14-21
180. O'Hara MW: Postpartum Depression: Causes and Consequences. New York, Springer-Verlag, 1994
181. O'Hara MW, Neunaber DH, Zekoski EM: Prospective study of postpartum depression: prevalence, course, and predictive tactors. J Abnorm Psychol 1984; 93:158-171
182. Wisner KL, Wheeler SB: Prevention of recurrent postpartum major depression. Hosp Community Psychiatry 1994; 45:1191-1196
183. Kastrup M, Lier L, Rafaelsen OJ: Psychiatric illness in relation to pregnancy and childbirth, I: methodologic considerations. Nordisk Psykiatrisk Tidsskrifr 1989; 43:531-534
184. Brockington IF, Cernik KF, Schofield EM, Downing AR, Francis AF, Keelan C: Puerperal psychosis. Arch Gen Psychiatry 1981; 38:829-833
185. Kendell RE, Chalmers JC, Platz C: Epidemiology of puerperal psychoses. Br J Psychiatry 1987; 150:662-673; correction, 151: 135
186. Paftenberger RS: Epidemiological aspects of mental illness associated with childbirth, in Motherhood and Mental Illness. Edited by Brockington IF, Kumar R. New York, Grune & Stratton, 1982, pp 19-36
187. Reich T, Winokur G: Postpartum psychosis in patients with manic depressive disease. J Nerv Ment Dis 1970; 151:60-68
188. Faedda GL, Tondo L, Baldessarini RJ, Suppes T, Tohen M: Outcome after rapid vs gradual discontinuation of lithium treatment in bipolar mood disorders. Arch Gen Psychiatry 1993; 50: 448-455
189. Stewart DE, Klompenhouwer JL, Kendell RE, van Hulst AM: Prophylactic lithium in puerperal psychoses: the experience of three centres. Br J Psychiatry 1991; 58:393-397
190. Cohen LS, Sichel DA, Robertson LM, Heckscher E, Rosenbaum JF: Postpartum prophylaxis for women with bipolar disorder. Am J Psychiatry 1995; 152:1641-1645
191. Dansky L, Rosenblatt D, Andermann E: Mechanisms of teratogenesis: folic acid and antiepileptic therapy. Neurology 1992; 42(suppl 5):32-42
192. Wegner C, Nau H: Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis. Neurology 1992; 42(suppl 5):17-24
193. MRC Vitamin Study Research Group: Prevention of neuraltube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338:131-137
194. Barron W, Mujais S, Zinaman M, Bravo EL, Lindheimer MD: Plasma catecholamine responses to physiologic stimuli in normal human pregnancy. Am J Obstet Gynecol 1986; 154:80-84
195. Pernoll M, Metcalfe J, Kovach P, Wachtel R, Dunham MJ: Ventilation during rest and exercise in pregnancy and postpartum. Respir Physiol 1975; 25:295-310
196. Cohen LS, Heller VL, Kelley KL: Course of panic disorder in 24 pregnant women, in CME Syllabus and Proceedings Summary, 142nd Annual Meeting of the American Psychiatric Association. Washington, DC, APA, 1989
197. Northcott CJ, Stein MB: Panic disorder in pregnancy. J Clin Psychiatry 1994; 55:539-542
198. Cowley DS, Roy-Byrne PP: Panic disorder during pregnancy. J Psychosom Obstet Gynaecol 1989; 10:193-210
199. George DT, Ladenheim JA, Nutt DJ: Effect of pregnancy on panic attacks. Am J Psychiatry 1987; 144:1078-1079
200. Klein D: Delineation of two drug-responsive syndromes. Psychopharmacologia 1964; 5:397-408
201. Villeponteaux V, Lydiard B, Laraia M, Stuart G, Ballenger J: The effects of pregnancy on pre-existing panic disorder. J Clin Psychiatry 1992; 53:201-205
202. Cohen LS, Rosenbaum J, Heller VL: Panic attack-associated placental abruption: a case report. J Clin Psychiatry 1989; 50: 266-267
203. Barlow DH, Cerny JA: The Psychological Treatment of Panic. New York, Guilford Press, 1988
204. Buttolph ML, Holland DA: Obsessive-compulsive disorders in pregnancy and childbirth, in Obsessive-Compulsive Disorders: Theory and Management, 2nd ed. Edited by Jenike MA, Baer L, Minichiello WE. Chicago, Year Book Medical, 1990, pp 89-97
205. Ingram IM: Obsessive illness in mental hospital patients. J Ment Sci 1961; 107:382-402
206. Neziroglu F, Anemone R, Yaryura-Tobias JA: Onset of obsessive-compulsive disorder in pregnancy. Am J Psychiatry 1992; 149:947-950
207. Lo WH: A follow-up study of obsessional neurotics in Hong Kong Chinese. Br J Psychiatry 1967; 113:823-832
208. Weltzin TE, Cameron J, Berga S, Kaye WH: Prediction of reproductive status in women with bulimia nervosa by past high weight. Am J Psychiatry 1994; 151:136-138
209. Treasure JL, Wheeler M, King EA, Gordon PAL, Russell GFM: Weight gain and reproductive function: uttrasonographic and endocrine features in anorexia nervosa. Clin Endocrinol (Oxf) 1988; 29:607-616
210. Edelstein CK, King BH: Pregnancy and eating disorders, in Special Problems in Managing Eating Disorders. Edited by Yager J, Gwirtsman HE, Edelstein CK. Washington, DC, American Psychiatric Press, 1992, pp 163-184
211. Lacey JH, Smith G: Bulimia nervosa: the impact of pregnancy on mother and baby. Br J Psychiatry 1987; 150:777-781
212. Brinch M, Isager T, Tolstrup K: Anorexia nervosa and motherhood: reproduction pattern and mothering behavior of 50 women. Acta Psychiatr Scand 1988; 77:611-617
213. Lemberg R, Phillips J: The impact of pregnancy on anorexia nervosa and bulimia. Int J Eat Disord 1989; 8:285-295
214. Stewart DE, Raskin J, Garfinkel PE, MacDonald OL, Robinson GE: Anorexia nervosa, bulimia and pregnancy. Am J Obstet Gynecol 1987; 157:1194-1198
215. Treasure JL, Russell GF: Intrauterine growth and neonatal weight gain in babies of women with anorexia nervosa. Br Med J Clin Res 1988; 296:1038
216. Willis DC, Rand CS: Pregnancy in bulimic women. Obstet Gynecol 1988; 71:708-710
217. Hediger ML, Scholl TO, Belsky DH, Ances IG, Salmon RW: Patterns of weight gain in adolescent pregnancy: effects on birth weight and preterm delivery. Obstet Gynecol 1989; 74:6-12